[Application of metagenomic next-generation sequencing technology in preterm infants with sepsis following antibiotic

Chun-Yan Lou1, Yu-Ning Liu1, Xuan Zhang1

  • 1Department of Neonatology, Henan Provincial People's Hospital/Zhengzhou University People's Hospital, Zhengzhou 450003, China.

Abstract

Insights

Metagenomic next-generation sequencing (mNGS) offers a higher pathogen detection rate for sepsis in preterm infants than blood culture, even after antibiotic use. This advanced diagnostic tool aids in timely and effective treatment adjustments.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Sepsis is a critical concern in preterm infants, often complicated by prior antibiotic exposure.
  • Accurate etiological diagnosis is essential for guiding appropriate antimicrobial therapy in this vulnerable population.
  • Traditional diagnostic methods like blood culture have limitations, especially in infants receiving antibiotics.

Purpose of the Study:

  • To evaluate the diagnostic value of metagenomic next-generation sequencing (mNGS) for sepsis in preterm infants.
  • To compare the pathogen detection rates of mNGS versus blood culture in preterm infants with sepsis, particularly after antibiotic treatment.

Main Methods:

  • Retrospective analysis of 45 preterm infants diagnosed with sepsis.
  • All infants received at least 3 days of antibiotic treatment prior to testing.
  • Comparison of pathogen detection by blood culture and blood mNGS.

Main Results:

  • Blood mNGS demonstrated a significantly higher pathogen detection rate (44%) compared to blood culture (4%).
  • mNGS identified a diverse range of pathogens, including bacteria and fungi, irrespective of antibiotic treatment duration (>10 days or ≤10 days).
  • Treatment plan adjustments based on mNGS results led to an 85% effectiveness rate.

Conclusions:

  • Blood mNGS is a more sensitive diagnostic tool for identifying pathogens in preterm infants with sepsis, even post-antibiotic exposure.
  • The effectiveness of mNGS is not diminished by the duration of prior antibiotic use.
  • mNGS should be considered for etiological diagnosis when clinical suspicion of sepsis is high, but blood cultures are negative.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...